Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma
Liver cancer is the fifth most common cancer in men, the seventh Gardening Book most common in women, and the third most common cause of death from cancer worldwide.Only 30-40% of liver cancer patients present early enough to undergo curative treatments such as surgery or liver transplantation.Local treatment with radiofrequency ablation or Twin TO